Ads

You May Also Like

Conatus Announces Results from ENCORE-PH Phase 2b Clinical Trial in NASH Cirrhosis

- Clinically Meaningful Improvements in Portal Hypertension in High Risk Compensated Cirrhosis Patients - ...

Galena Biopharma and BioVascular, Inc. Reaffirm GALE-401 Partnership

SAN RAMON, Calif., Sept. 11, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a ...